Bruce is a partner and focuses on the discovery and development of novel medicines and therapeutic platforms. Prior to joining Atlas in 2005, Bruce was a consultant at McKinsey & Company, as well as an investor for Caxton Health Holdings. As a British Marshall Scholar, Bruce received a D.Phil. (PhD) in molecular immunology from Oxford University. He received a BS in biochemistry, summa cum laude, from The Pennsylvania State University.

Bruce serves or has served as an advisor in various capacities to Takeda, UCB, the Gates Foundation, Dana Farber’s Binney Street Capital, and the Penn State Research Foundation. He also serves on the board of New England Disabled Sports, a charity dedicated to adaptive sports. Bruce blogs about biotech and venture capital topics at http://LifeSciVC.com .